Latest Breaking News On - Michigan healthcare professionals - Page 1 : comparemela.com

PreludeDx™ to Present Data in DCIS and Stage I, II Early Breast Cancer at the 2024 Miami Breast Cancer Conference

/PRNewswire/ Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced that.

Cleveland clinicUnited statesMiami beachFranka viciniTroy bremerAndrew wadeChirags shahDan forcheCory dunnPrelude corporation preludedxNational cancer instituteTaussig cancer instituteUniversity of california san franciscoDepartment of radiation oncologyPrelude corporationBreast cancer conference

Agendia, Inc : Agendia Announces First Patient Enrolled in DEBRA Trial Using MammaPrint

Agendia, Inc : Agendia Announces First Patient Enrolled in DEBRA Trial Using MammaPrint
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNoord hollandVito antonucciEric brownStefan klotterWilliam audehMegan kernanMichigan healthcare professional radiation oncology instituteA division of michigan healthcare professionalsMichigan health professionals teamHormone sensitiveBreast radiationLow risk mammaprintComprehensive breast careMichigan healthcare professionalsMammaprint low risk

Agendia Announces First Patient Enrolled in DEBRA Trial Using MammaPrint®

IRVINE, Calif. & AMSTERDAM (BUSINESS WIRE) Feb 1, 2024

United statesNoord hollandMegan kernanEric brownVito antonucciWilliam audehA division of michigan healthcare professionalsMichigan healthcare professional radiation oncology instituteMichigan health professionals teamAgendia incBreast radiationLow risk mammaprintComprehensive breast careMichigan healthcare professionalsMammaprint low riskRadiation oncologist

PreludeDx™ to Present New DCISionRT® Comparative Data in

Data to Address Limitations in the Applications of Clinicopathologic Factors .

Laguna hillsUnited statesUniversity of california san franciscoSan diegoSan diego convention centerFranka viciniDan forcheCory dunnChirags shahTroy bremerAndrew wadePrelude corporationNational cancer instituteAmerican society for radiation oncologyPrelude corporation preludedxTaussig cancer institute

Concurrent Radiation Boost Comparable to Sequential Boost in High-Risk Breast Cancer

A concurrent radiation boost produces comparable outcomes as a sequential boost in patients with high-risk breast cancer, a phase 3 study suggests.

Franka viciniMichigan healthcare professionals